EUVIMEDEUVIMED entdecken
Leitlinie

Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice

Mohamed Abdellatif

International Journal of Clinical Pharmacy and Medicine · 10.07.2026 · 1 (2)

DOI: 10.68760/ijcpm.2026.05 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Clinical Pharmacy and Medicine, online erschienen am 10.07.2026. Verfasst von Mohamed Abdellatif.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abdellatif, M. (2026). Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice. International Journal of Clinical Pharmacy and Medicine, 1(2). https://doi.org/10.68760/ijcpm.2026.05

Vancouver

Abdellatif M. Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice. International Journal of Clinical Pharmacy and Medicine. 2026;1(2). doi:10.68760/ijcpm.2026.05

BibTeX
@article{Abdellatif2026,
  author = {Abdellatif, Mohamed},
  title = {Guideline Concordance for HFrEF Therapy in the United Arab Emirates: Retrospective Real-World Data Benchmarked Against Canadian Practice},
  journal = {International Journal of Clinical Pharmacy and Medicine},
  year = {2026},
  volume = {1},
  number = {2},
  doi = {10.68760/ijcpm.2026.05}
}
Kostenlos starten →